144 related articles for article (PubMed ID: 8905401)
1. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
Adler G; Pacuszka T; Strugalska M; Targońska I; Panasiewicz M; Lewartowska A
Immunol Lett; 1996 Sep; 52(2-3):89-93. PubMed ID: 8905401
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. Glycolipids noncovalently bound to DEAE-Sephadex. Use of the complexes for purification of IgM and IgG anti-(Gal beta 1-->3 GalNAc-) antibodies.
Rodriguez PE; Barra JL; Cumar FA
Biochem Mol Biol Int; 1994 May; 33(2):273-81. PubMed ID: 7524899
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside reactive antibodies of IgG and IgM class in sera of patients with differentiated thyroid cancer.
Lewartowska A; Pacuszka T; Adler G; Panasiewicz M; Wojciechowska W
Immunol Lett; 2002 Feb; 80(2):129-32. PubMed ID: 11750045
[TBL] [Abstract][Full Text] [Related]
5. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.
Quattrini A; Lorenzetti I; Sciorati C; Corbo M; Previtali SC; Feltri ML; Canal N; Wrabetz L; Nemni R; Clementi E
J Neuroimmunol; 2001 Mar; 114(1-2):213-9. PubMed ID: 11240034
[TBL] [Abstract][Full Text] [Related]
6. Incidental presence of antibodies against gangliosides in Graves' disease.
Adler G; Pacuszka T; Targonska I; Lewartowska A; Nauman J
Autoimmunity; 1994; 18(2):149-52. PubMed ID: 7742477
[TBL] [Abstract][Full Text] [Related]
7. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test.
Adler G; Pacuszka T; Lewartowska A; Rowinska E; Oblakowski P; Panasiewicz M
Lung Cancer; 2001 Dec; 34(3):383-5. PubMed ID: 11714535
[TBL] [Abstract][Full Text] [Related]
9. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
[TBL] [Abstract][Full Text] [Related]
10. Anti-GM1 ganglioside antibodies in Parkinson's disease.
Zappia M; Crescibene L; Bosco D; Arabia G; Nicoletti G; Bagalà A; Bastone L; Napoli ID; Caracciolo M; Bonavita S; Di Costanzo A; Gambardella A; Quattrone A
Acta Neurol Scand; 2002 Jul; 106(1):54-7. PubMed ID: 12067330
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
12. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
Pestronk A; Choksi R
Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
[TBL] [Abstract][Full Text] [Related]
14. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
Niebroj-Dobosz I; Janik P; Kwieciński H
Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
[TBL] [Abstract][Full Text] [Related]
15. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?
Bartolomei F; Boucraut J; Barrié M; Kok J; Dravet C; Viallat D; Bernard D; Gastaut JL
Epilepsia; 1996 Oct; 37(10):922-6. PubMed ID: 8822688
[TBL] [Abstract][Full Text] [Related]
16. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
[TBL] [Abstract][Full Text] [Related]
18. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
Bech E; Jakobsen J; Orntoft TF
Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
[TBL] [Abstract][Full Text] [Related]
19. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
Lardone RD; Yuki N; Irazoqui FJ; Nores GA
Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to fucogangliosides in neurological diseases.
Yuki N; Ariga T
J Neurol Sci; 1997 Sep; 150(1):81-4. PubMed ID: 9260862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
